John Deedrick is listed as an executive officer and director on 19 SEC Form D filings by 7 issuers between Apr 2009 and Oct 2023. Largest by amount reported sold: Endogenex, Inc. (Plymouth, MN — other health care — 2018–2023; $69.6M reported sold to 11 investors), NEVRO CORP (Menlo Park, CA — biotechnology — 2010–2011; $58.6M reported sold to 13 investors), MYOSCIENCE, INC (Fremont, CA — industry reported as "Other" — 2010; $32.7M reported sold to 35 investors), TORAX MEDICAL INC (Shoreview, MN — biotechnology — 2009–2011; $25M reported sold to 17 investors), ActivOrtho, Inc. (Plymouth, MN — other technology — 2017–2022; $1.12M reported sold to 26 investors) and 2 more (all listed below).
What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $188.2M sold in total.
Listed alongside Paul Hindrichs (10 shared filings), Michael Brenzel (8 shared filings), Andrew Palmer (7 shared filings), Paul Buckman (6 shared filings), Robert A. Kukuljan (6 shared filings) and 45 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 2 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 19 public filings for John Deedrick and found 16 differences, 2 worth asking the sponsor about: 6 filings report more than 10% of the money raised going to insiders; Form D filed 110 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.